Fusion of the labia

Q17_FUSION_OF_THE_LABIA

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519972
1. Apply sex-specific rule None	519972
2. Check conditions None	519972
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — Q52.5 Cause of death: ICD-10 — Q52.5 2 out of 7 registries used, show all original rules.	40
4. Check minimum number of events None	40
5. Include endpoints None	40
6. Filter based on genotype QC (FinnGen only)	34

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

NAME	Q17_FUSION_OF_THE_LABIA
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	Q525
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	Q525
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Fusion of the labia based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

No upset plot: unknown.

No upset table: unknown.

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded (different definition than used in FinnGen).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	34	34	-
Unadjusted period prevalence (%)	0.01	0.01	-
Median age at first event (years)	4.33	4.33	-

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

No data available

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

3.92

1.67

1.4

7.4

22.62

24.71

mmol/l

—

(3022313) Gas panel - Capillary blood

3.65

1.57

1.2

7.4

—

(3007853) Bacteria identified in Skin by Aerobe culture

0.00

1.42

0.0

1.5

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

2.40

1.42

1.1

1.0

—

(3016879) Cocaine [Presence] in Urine

2.52

1.33

1.3

2.2

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

2.85

1.25

1.2

—

(3027944) Amphetamines [Presence] in Urine

2.31

1.24

1.3

2.2

—

(3000764) Benzodiazepines [Presence] in Urine

2.24

1.20

1.3

2.2

—

(3027008) Opiates [Presence] in Urine

2.24

1.20

1.3

2.1

—

(3028300) Cannabinoids [Presence] in Urine

2.18

1.16

1.3

2.2

—

(3013512) EKG study

2.28

1.15

2.8

2.9

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

2.57

1.12

1.4

5.5

5.10

5.07

kpa

—

(3011288) Drugs identified in Urine by Screen method

2.35

1.12

1.1

2.9

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

1.89

0.91

1.3

2.1

2.29

2.40

mmol/l

1.60

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

166

1.72

0.86

1.5

3.0

18.82

25.14

u/l

0.95

156

(1001926) Buprenorphine [Presence] in Urine by Screen method

1.96

0.83

1.0

2.3

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

0.00

0.82

0.0

2.1

—

2.75

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

0.00

0.80

0.0

1.5

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

0.00

0.80

0.0

1.5

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

176

0.61

0.66

1.3

2.1

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

0.00

0.62

0.0

1.6

—

1.23

—

(40768804) Tissue Pathology biopsy report

1.64

0.60

1.6

2.0

—

(3037467) Urinalysis macro (dipstick) panel - Urine

227

1.58

0.60

3.5

3.9

—

(3041096) Erythrocytes [Presence] in Urine by Automated

102

1.57

0.57

2.6

3.2

—

(40761536) Microorganisms panel - Urine sediment

1.59

0.54

2.5

2.8

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

132

1.50

0.52

3.5

3.4

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

1.59

0.51

1.7

2.4

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

1.64

0.44

1.2

1.5

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

1.64

0.44

1.2

1.5

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

1.64

0.44

1.2

1.5

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

1.64

0.44

1.2

1.5

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

0.00

0.42

0.0

1.3

—

(4200892) Spirometry reversibility

0.00

0.42

0.0

1.2

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

0.00

0.41

0.0

3.9

—

91.89

—

(3035350) Ketones [Presence] in Urine by Test strip

168

1.38

0.38

3.5

3.3

0.00

estimate

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

151

0.71

0.37

1.4

2.4

—

(1761868) Lipid panel - Serum or Plasma

1.47

0.36

1.4

1.8

—

(3019198) Lymphocytes [#/volume] in Blood

170

0.73

0.34

3.4

4.1

1.92

2.06

e9/l

0.39

151

(40761511) CBC panel - Blood by Automated count

345

0.75

0.32

7.0

7.6

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

187

0.76

0.29

2.3

2.2

—

(3001604) Monocytes [#/volume] in Blood

156

0.75

0.28

3.7

4.3

0.50

0.52

e9/l

0.16

136

(3006315) Basophils [#/volume] in Blood

156

0.75

0.28

3.7

4.3

0.03

e9/l

0.08

136

(3048689) Calprotectin [Mass/mass] in Stool

1.26

0.27

1.2

1.9

25.22

45.57

ug/g

—

(40758558) Short blood count panel - Blood

1.26

0.27

2.0

3.6

—

(3044640) Blood type and Crossmatch panel - Blood

0.72

0.26

1.0

1.7

—

(3013115) Eosinophils [#/volume] in Blood

164

0.77

0.24

3.6

4.2

0.11

0.17

e9/l

2.00

143

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

1.33

0.23

1.3

1.4

—

(3003338) MCHC [Mass/volume]

310

0.77

0.22

6.2

10.3

333.00

332.79

g/l

0.05

304

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

0.00

0.21

0.0

2.0

—

6.69

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

0.00

0.21

0.0

1.5

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

0.00

0.21

0.0

1.1

—

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

0.00

0.21

0.0

3.6

—

53.00

—

(3030905) Polymorphonuclear cells [#/volume] in Blood

0.00

0.21

0.0

3.6

—

3.07

—

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

0.00

0.21

0.0

2.4

—

43.36

—

(3014007) Fractional oxyhemoglobin in Arterial blood

0.00

0.21

0.0

14.9

—

94.38

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

0.00

0.21

0.0

1.2

—

1.25

—

(3034770) Mitochondria Ab [Titer] in Serum

0.00

0.21

0.0

2.3

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

0.00

0.21

0.0

1.2

—

0.22

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

0.00

0.21

0.0

5.3

—

3.27

—

(40768443) Skin Pathology biopsy report

0.00

0.21

0.0

1.2

—

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

0.00

0.21

0.0

13.8

—

0.76

—

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

0.00

0.21

0.0

13.8

—

1.01

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

0.00

0.21

0.0

4.7

—

169.62

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

0.00

0.21

0.0

1.4

—

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

0.00

0.21

0.0

1.4

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

0.00

0.21

0.0

1.5

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

0.00

0.20

0.0

1.2

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

0.00

0.20

0.0

2.1

—

7.56

—

(3021601) Nitrite [Presence] in Urine by Test strip

169

1.24

0.20

4.6

0.00

estimate

—

(3003694) ABO and Rh group [Type] in Blood

149

0.81

0.17

1.5

1.8

—

(3009261) Glucose [Presence] in Urine by Test strip

171

1.21

0.17

3.7

3.4

0.00

estimate

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

158

0.82

0.16

3.2

2.6

—

(40760892) CBC W Ordered Manual Differential panel - Blood

157

0.83

0.14

2.7

4.8

—

(3018095) Leukocytes [#/volume] in Urine

116

0.82

0.14

1.7

3.4

10.96

81.98

e6/l

—

(3026008) Bacteria identified in Urine by Culture

134

1.19

0.13

2.3

2.7

—

(3044889) 12 lead EKG panel

145

0.85

0.12

1.9

2.2

—

(3019832) Treponema pallidum Ab [Presence] in Serum

134

0.85

0.10

1.4

1.9

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

1.18

0.10

1.7

2.0

—

(36660697) Celiac disease serology panel - Serum

1.06

0.09

1.0

1.1

—

(3050129) First trimester maternal screen panel - Serum or Plasma

0.83

0.09

1.4

1.3

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

337

0.88

0.09

4.8

4.3

—

(3009508) Creatinine [Moles/volume] in Urine

1.07

0.08

2.3

2.7

7.03

8.67

mmol/l

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

0.86

0.08

1.6

—

(3031040) Bacteria [#/volume] in Urine by Automated count

238

1.13

0.07

4.6

4.0

—

68.60

—

(36304419) Bacteria [Presence] in Urine

0.85

0.07

1.6

2.9

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

119

1.14

0.07

1.9

2.1

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

151

0.89

0.06

3.1

2.4

—

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

100

1.14

0.06

3.5

4.8

12.46

9.58

umol/l

0.54

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

106

0.92

0.01

2.1

3.3

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

141

0.99

0.00

1.6

1.8

—

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

123

0.97

0.00

3.3

5.9

1.20

1.22

mmol/l

0.59

105

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

115

0.94

0.00

1.6

2.4

70.00

65.38

nmol/l

0.30

101

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

247

1.03

0.00

5.4

6.4

106.40

106.21

ml/min/173m2

0.01

182

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

181

0.99

0.00

3.6

4.7

76.83

78.64

u/l

0.05

167

(3025018) Bordetella pertussis Ab [Titer] in Serum

0.00

0.0

1.2

—

(3035285) Chloride [Moles/volume] in Venous blood

0.00

0.0

1.4

—

108.20

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

1.02

0.00

1.3

1.5

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.0

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

0.00

0.0

2.0

—

6.88

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.0

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

0.93

0.00

4.0

2.8

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.0

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

0.00

0.0

1.0

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

0.00

0.0

1.4

—

(3002523) Influenza virus A Ag [Presence] in Specimen

0.00

0.0

1.0

—

(3041354) Potassium [Moles/volume] in Venous blood

0.00

0.0

1.4

—

3.92

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

0.00

0.0

1.0

—

(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

0.00

0.0

5.6

—

1.10

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

0.00

0.0

1.8

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

0.00

0.0

1.0

—

(3003740) Influenza virus B Ag [Presence] in Specimen

0.00

0.0

1.0

—

(3004588) Protein electrophoresis panel - Serum or Plasma

0.00

0.0

1.2

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

0.00

0.0

1.0

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

0.00

0.0

1.4

—

(3021901) Oxygen saturation in Capillary blood

0.00

0.0

1.0

—

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

0.00

0.0

2.8

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

0.00

0.0

1.1

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

0.00

0.0

1.0

—

50.00

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

0.00

0.0

1.2

—

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

0.00

0.0

1.7

—

0.62

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

0.00

0.0

1.1

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.0

—

48.50

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

0.00

-0.00

0.0

1.0

—

121.83

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

320

1.00

-0.00

6.1

8.5

13.90

21.05

mg/l

0.98

241

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

0.00

-0.00

0.0

1.2

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

0.00

-0.00

0.0

1.0

—

95.67

—

(3010838) Calcium [Moles/time] in 24 hour Urine

0.00

-0.00

0.0

2.4

—

3.63

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

308

1.03

-0.00

5.2

5.9

21.26

21.88

u/l

0.10

288

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

0.00

-0.00

0.0

1.0

—

(3008037) Lactate [Moles/volume] in Venous blood

0.00

-0.00

0.0

1.7

—

1.34

—

(40768793) Breast Pathology biopsy report

0.00

-0.00

0.0

1.3

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.4

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

0.00

-0.00

0.0

1.0

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

0.00

-0.00

0.0

1.7

—

22.58

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

0.00

-0.00

0.0

1.3

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.2

—

(3020891) Body temperature

0.00

-0.00

0.0

2.1

—

(3018405) Lactate [Moles/volume] in Arterial blood

0.00

-0.00

0.0

1.7

—

1.00

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

0.88

-0.00

1.3

1.9

—

(3043409) Potassium [Moles/volume] in Arterial blood

0.00

-0.00

0.0

1.7

—

4.17

—

(3044290) Cell count panel - Cerebral spinal fluid

0.00

-0.00

0.0

1.5

—

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

0.00

-0.00

0.0

1.0

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

0.00

-0.00

0.0

2.4

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

0.00

-0.00

0.0

2.2

—

(3052851) Hemolysis interference index of Serum or Plasma

0.00

-0.00

0.0

2.7

—

(3026389) Candida sp identified in Specimen by Organism specific culture

0.00

-0.00

0.0

1.0

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

0.00

-0.00

0.0

1.0

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

0.00

-0.00

0.0

1.5

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3038515) Glucose [Moles/volume] in Venous blood

0.00

-0.00

0.0

1.7

—

5.99

—

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

3.8

—

28.90

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

0.00

-0.00

0.0

1.0

—

Mortality – FinRegistry

↥

This endpoint is excluded (different definition than used in FinnGen).

Relationships between endpoints

↥

Index endpoint: Q17_FUSION_OF_THE_LABIA – Fusion of the labia

GWS hits: -

This endpoint is excluded (different definition than used in FinnGen).

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Fusion of the labia

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

LabWAS

Mortality – FinRegistry

Relationships between endpoints